argenx SE (ARGX)
USD 581.14
(6.39%)
USD 581.14
(6.39%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -295.05 Million USD | 58.42% |
| 2022 | -709.59 Million USD | -73.81% |
| 2021 | -408.26 Million USD | 37.24% |
| 2020 | -650.54 Million EUR | -256.37% |
| 2019 | -182.54 Million EUR | -139.47% |
| 2018 | -76.23 Million EUR | -126.32% |
| 2017 | -33.68 Million EUR | -49.84% |
| 2016 | -22.47 Million EUR | -34.28% |
| 2015 | -16.74 Million EUR | -33.48% |
| 2014 | -12.54 Million EUR | -48.14% |
| 2013 | -8.46 Million EUR | 33.99% |
| 2012 | -12.82 Million EUR | -185.59% |
| 2011 | -4.49 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -32.48 Million USD | 47.27% |
| 2024 Q1 | -61.59 Million USD | 37.98% |
| 2023 Q2 | -94.36 Million USD | -226.86% |
| 2023 Q1 | -28.87 Million USD | 25.23% |
| 2023 FY | -295.05 Million USD | 58.42% |
| 2023 Q3 | -72.64 Million USD | 23.02% |
| 2023 Q4 | -99.31 Million USD | -36.72% |
| 2022 Q3 | -235.04 Million USD | -12.6% |
| 2022 Q4 | -38.61 Million USD | 83.57% |
| 2022 Q1 | -227.18 Million USD | 4.47% |
| 2022 Q2 | -208.74 Million USD | 8.12% |
| 2022 FY | -709.59 Million USD | -73.81% |
| 2021 Q4 | -237.81 Million USD | -1.8% |
| 2021 FY | -408.26 Million USD | 37.24% |
| 2021 Q1 | -40.43 Million EUR | -114.0% |
| 2021 Q2 | 103.6 Million USD | 356.23% |
| 2021 Q3 | -233.61 Million USD | -325.5% |
| 2020 Q4 | 288.9 Million USD | 283.25% |
| 2020 FY | -650.54 Million EUR | -256.37% |
| 2020 Q3 | -157.65 Million EUR | 0.0% |
| 2019 Q2 | -58.88 Million EUR | -876.89% |
| 2019 Q4 | -92.9 Million EUR | -272.59% |
| 2019 FY | -182.54 Million EUR | -139.47% |
| 2019 Q1 | 7.57 Million EUR | 122.36% |
| 2019 Q3 | -24.93 Million EUR | 57.65% |
| 2018 FY | -76.23 Million EUR | -126.32% |
| 2018 Q2 | -1.44 Million EUR | 93.37% |
| 2018 Q4 | -33.89 Million EUR | -77.2% |
| 2018 Q3 | -19.12 Million EUR | -1224.58% |
| 2018 Q1 | -21.76 Million EUR | -51.72% |
| 2017 FY | -33.68 Million EUR | -49.84% |
| 2017 Q4 | -14.34 Million EUR | -44.05% |
| 2017 Q3 | -9.96 Million EUR | -2470.1% |
| 2017 Q2 | -387.54 Thousand EUR | 95.69% |
| 2017 Q1 | -8.98 Million EUR | -7.25% |
| 2016 Q1 | -3.36 Million EUR | 37.72% |
| 2016 FY | -22.47 Million EUR | -34.28% |
| 2016 Q4 | -8.37 Million EUR | -41.6% |
| 2016 Q3 | -5.91 Million EUR | -22.86% |
| 2016 Q2 | -4.81 Million EUR | -43.09% |
| 2015 Q1 | -3.22 Million EUR | 29.28% |
| 2015 FY | -16.74 Million EUR | -33.48% |
| 2015 Q4 | -5.4 Million EUR | -56.02% |
| 2015 Q3 | -3.46 Million EUR | 25.45% |
| 2015 Q2 | -4.64 Million EUR | -44.03% |
| 2014 Q2 | -3.67 Million EUR | -43.47% |
| 2014 FY | -12.54 Million EUR | -48.14% |
| 2014 Q4 | -4.56 Million EUR | -161.37% |
| 2014 Q3 | -1.74 Million EUR | 52.49% |
| 2014 Q1 | -2.56 Million EUR | -22.83% |
| 2013 Q3 | -102.69 Thousand EUR | 97.41% |
| 2013 Q2 | -3.95 Million EUR | -70.73% |
| 2013 Q1 | -2.31 Million EUR | 0.0% |
| 2013 FY | -8.46 Million EUR | 33.99% |
| 2013 Q4 | -2.08 Million EUR | -1930.17% |
| 2012 FY | -12.82 Million EUR | -185.59% |
| 2011 FY | -4.49 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Caribou Biosciences, Inc. | -102.07 Million USD | -189.069% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -1450.553% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -739.65% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -477.878% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -46.361% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -122.693% |
| Agenus Inc. | -245.76 Million USD | -20.057% |
| Fortress Biotech, Inc. | -60.63 Million USD | -386.589% |
| GlycoMimetics, Inc. | -36.89 Million USD | -699.614% |
| Novavax, Inc. | -545.06 Million USD | 45.868% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -92.855% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -31422.756% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -200.624% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -4313.657% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -468.229% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 32.979% |
| AlloVir, Inc. | -190.41 Million USD | -54.95% |
| Aptorum Group Limited | -2.82 Million USD | -10345.659% |
| Ardelyx, Inc. | -66.06 Million USD | -346.597% |
| Bicycle Therapeutics plc | -180.66 Million USD | -63.316% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -64.785% |
| Chimerix, Inc. | -82.09 Million USD | -259.404% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -561.505% |
| CRISPR Therapeutics AG | -153.61 Million USD | -92.079% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -808.275% |
| Precision BioSciences, Inc. | -61.31 Million USD | -381.177% |
| Dyadic International, Inc. | -6.79 Million USD | -4241.913% |
| Elevation Oncology, Inc. | -45.7 Million USD | -545.574% |
| Fortress Biotech, Inc. | -60.63 Million USD | -386.589% |
| GT Biopharma, Inc. | -7.59 Million USD | -3783.809% |
| Alkermes plc | 355.75 Million USD | 182.937% |
| Immix Biopharma, Inc. | -15.42 Million USD | -1812.693% |
| Innoviva, Inc. | 179.72 Million USD | 264.172% |
| IO Biotech, Inc. | -86.08 Million USD | -242.754% |
| Jaguar Health, Inc. | -41.3 Million USD | -614.414% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 665.734% |
| ContextLogic Inc. | -317 Million USD | 6.923% |
| AbCellera Biologics Inc. | -146.39 Million USD | -101.542% |
| Lantern Pharma Inc. | -15.96 Million USD | -1748.525% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -3370.803% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -43.735% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 21.031% |
| MEI Pharma, Inc. | 17.77 Million USD | 1759.652% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -302.27% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1112.25% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -108.658% |
| NextCure, Inc. | -62.72 Million USD | -370.406% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -261.673% |
| ChromaDex Corporation | -4.93 Million USD | -5875.152% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -161.199% |
| Incyte Corporation | 597.59 Million USD | 149.373% |
| Opthea Limited | -220.24 Million USD | -33.968% |
| MiMedx Group, Inc. | 67.43 Million USD | 537.511% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -400.237% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -348.647% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -476.737% |
| Vaxcyte, Inc. | -402.26 Million USD | 26.652% |
| PDS Biotechnology Corporation | -42.94 Million USD | -587.093% |
| Pharming Group N.V. | -10.54 Million USD | -2697.241% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -1102.188% |
| Onconetix, Inc. | -37.4 Million USD | -688.707% |
| Acelyrin, Inc. | -381.64 Million USD | 22.688% |
| PureTech Health plc | -65.69 Million USD | -349.112% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -299.855% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -39.032% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1490.917% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1112.25% |
| ESSA Pharma Inc. | -26.58 Million USD | -1009.959% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1075.932% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -2854.667% |
| Seer, Inc. | -86.27 Million USD | -241.983% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -14.437% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -690.179% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -983.24% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -2352290.117% |
| Summit Therapeutics Inc. | -614.92 Million USD | 52.018% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -765.233% |
| Senti Biosciences, Inc. | -92.91 Million USD | -217.538% |
| ImmuCell Corporation | -5.77 Million USD | -5009.499% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -79.283% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -406.155% |
| Precigen, Inc. | -95.9 Million USD | -207.655% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -442.158% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -647.367% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -181.811% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -373.943% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -2157.161% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 48.493% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -340.41% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -904.88% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -937.02% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1354.108% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -413.02% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -83.345% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -8123.328% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -22.246% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 513.182% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -500.678% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -2866.029% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -20.138% |
| Aptose Biosciences Inc. | -51.2 Million USD | -476.197% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -200.162% |
| Soligenix, Inc. | -6.14 Million USD | -4704.852% |
| Century Therapeutics, Inc. | -136.67 Million USD | -115.882% |
| Kura Oncology, Inc. | -152.63 Million USD | -93.311% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -230.71% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -2699.896% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 52278.365% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -51754.657% |
| Autolus Therapeutics plc | -208.38 Million USD | -41.592% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -310.377% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -316.771% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -1261.699% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -30.989% |
| GRI Bio, Inc. | -13.03 Million USD | -2163.197% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -7036.23% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -137.785% |
| IGM Biosciences, Inc. | -246.41 Million USD | -19.738% |
| INmune Bio, Inc. | -30 Million USD | -883.248% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -166.874% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -599.281% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1748.511% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -1768.017% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -394.35% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -191.649% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -6.854% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -24.028% |
| Verastem, Inc. | -87.36 Million USD | -237.717% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -444.499% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -82.881% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -152.921% |
| Histogen Inc. | -10.62 Million USD | -2678.015% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -1965.22% |
| Surrozen, Inc. | -43.04 Million USD | -585.5% |
| Organovo Holdings, Inc. | -14.67 Million USD | -1911.131% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -5700.105% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -463.735% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -1067.925% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -995.304% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -3430.573% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -95.289% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -503.059% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -892.609% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -2732.227% |
| Apollomics, Inc. | -172.6 Million USD | -70.945% |
| Amarin Corporation plc | -59.11 Million USD | -399.142% |
| Mesoblast Limited | -87.95 Million USD | -235.455% |
| Turnstone Biologics Corp. | -55.2 Million USD | -434.516% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -100.768% |
| Synaptogenix, Inc. | -6.03 Million USD | -4786.194% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -1720.416% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -278.176% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -6057.886% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -3411.618% |
| Exelixis, Inc. | 207.76 Million USD | 242.013% |
| Better Therapeutics, Inc. | -39.76 Million USD | -642.085% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -104.972% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 44.185% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2324.025% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -3685.308% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -859.553% |
| Gritstone bio, Inc. | -138.49 Million USD | -113.05% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -357.695% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -7276.417% |
| Avid Bioservices, Inc. | -140.75 Million USD | -109.625% |
| Insmed Incorporated | -749.56 Million USD | 60.637% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -1842.479% |
| MediWound Ltd. | -6.71 Million USD | -4293.285% |
| OmniAb, Inc. | -50.61 Million USD | -482.89% |
| Alector, Inc. | -130.39 Million USD | -126.283% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -159.447% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -469.084% |
| Zai Lab Limited | -334.62 Million USD | 11.824% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 8.93% |
| Aura Biosciences, Inc. | -76.4 Million USD | -286.155% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -25.751% |
| Immunic, Inc. | -93.61 Million USD | -215.187% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -117.122% |
| Veracyte, Inc. | -74.4 Million USD | -296.555% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -3744.063% |
| FibroGen, Inc. | -284.23 Million USD | -3.807% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1024.783% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -4113.905% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -1466.706% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 171.126% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -1208.149% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 698.837% |
| TG Therapeutics, Inc. | 12.67 Million USD | 2428.385% |
| Galecto, Inc. | -38.34 Million USD | -669.389% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -1463.94% |
| Fortrea Holdings Inc. | -3.4 Million USD | -8578.029% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -132.978% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -1594.636% |
| XBiotech Inc. | -24.55 Million USD | -1101.503% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -357.695% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -370.729% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -199.771% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1277.015% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -434.584% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 51.363% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -332.28% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -518136.906% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -30.244% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -1225.038% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -34.292% |
| NexImmune, Inc. | -32.34 Million USD | -812.223% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -5481.176% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -2000.635% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 107.463% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -1118.17% |
| Scopus BioPharma Inc. | -11.6 Million USD | -2441.407% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -152.618% |
| Ainos, Inc. | -13.77 Million USD | -2042.638% |
| Pluri Inc. | -20.88 Million USD | -1312.548% |
| Prothena Corporation plc | -147.02 Million USD | -100.678% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -159.112% |
| Celularity Inc. | -196.29 Million USD | -50.311% |
| Rallybio Corporation | -74.56 Million USD | -295.704% |
| Cue Biopharma, Inc. | -50.73 Million USD | -481.58% |
| MeiraGTx Holdings plc | -84.02 Million USD | -251.141% |
| Omeros Corporation | -117.81 Million USD | -150.442% |
| Humacyte, Inc. | -110.77 Million USD | -166.351% |
| Immunocore Holdings plc | -55.28 Million USD | -433.675% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1540.642% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -1186.699% |
| Blueprint Medicines Corporation | -506.98 Million USD | 41.802% |
| CalciMedica, Inc. | -34.35 Million USD | -758.786% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -335.985% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -77.969% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -4.165% |
| Pulmatrix, Inc. | -14.12 Million USD | -1989.463% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -738.338% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -257.043% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 38.683% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -181.349% |
| Cytokinetics, Incorporated | -526.24 Million USD | 43.932% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -718.115% |
| Nutriband Inc. | -5.48 Million USD | -5278.963% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -629.968% |
| Vor Biopharma Inc. | -117.86 Million USD | -150.336% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 106.785% |
| Evogene Ltd. | -23.87 Million USD | -1135.617% |
| ProKidney Corp. | -35.46 Million USD | -731.885% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -146.364% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -3660.846% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 54.127% |
| CorMedix Inc. | -46.33 Million USD | -536.724% |
| BioLineRx Ltd. | -60.61 Million USD | -386.774% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -189.995% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -618.485% |
| Atai Life Sciences N.V. | -40.22 Million USD | -633.525% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -265.843% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -290.69% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -0.979% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -958.448% |
| MediciNova, Inc. | -8.57 Million USD | -3342.25% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -139.341% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -3422.25% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1036.272% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -23.33% |
| Biomea Fusion, Inc. | -117.25 Million USD | -151.634% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 52.912% |
| Mereo BioPharma Group plc | -29.46 Million USD | -901.334% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -92.641% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -40.931% |
| Absci Corporation | -110.56 Million USD | -166.857% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -878.617% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -192.604% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -25.056% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 2194.952% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -52.907% |
| Allakos Inc. | -185.7 Million USD | -58.886% |
| Imunon, Inc. | -19.51 Million USD | -1411.931% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -203.131% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 377.985% |
| BioAtla, Inc. | -123.46 Million USD | -138.983% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2324.025% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -1735.135% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 9.843% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -698.541% |
| XOMA Corporation | -40.83 Million USD | -622.62% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -189.637% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -148.963% |
| aTyr Pharma, Inc. | -50.38 Million USD | -485.55% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -236.515% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -94.422% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -24.111% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -740.152% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -3546.258% |
| Akari Therapeutics, Plc | -10 Million USD | -2848.171% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -438151.764% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 204.78% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -4326.969% |
| UroGen Pharma Ltd. | -102.24 Million USD | -188.577% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -176.285% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -3693.828% |
| Orgenesis Inc. | -55.36 Million USD | -432.962% |
| Entera Bio Ltd. | -8.88 Million USD | -3219.305% |
| GH Research PLC | -35.58 Million USD | -729.103% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -1315.801% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -281.265% |
| Xencor, Inc. | -126.08 Million USD | -134.007% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -7735.272% |
| Replimune Group, Inc. | -215.79 Million USD | -36.729% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1287.405% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 11859.785% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -4326.969% |
| Portage Biotech Inc. | -75.33 Million USD | -291.634% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -3422.25% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -205.264% |
| OncoCyte Corporation | -27.78 Million USD | -962.068% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -2099.063% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -2552.992% |
| Purple Biotech Ltd. | -19.88 Million USD | -1384.17% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -4103.633% |
| scPharmaceuticals Inc. | -54.81 Million USD | -438.32% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1585.426% |
| HilleVax, Inc. | -123.56 Million USD | -138.782% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -2819.294% |
| Tharimmune, Inc. | -9.31 Million USD | -3066.112% |
| Genprex, Inc. | -30.86 Million USD | -856.087% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -25.062% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -880.438% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -16457.407% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -5471.227% |
| OKYO Pharma Limited | -16.82 Thousand USD | -1753510.302% |
| Savara Inc. | -54.69 Million USD | -439.422% |
| Curis, Inc. | -47.41 Million USD | -522.304% |
| Daré Bioscience, Inc. | -30.16 Million USD | -878.247% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -1810.336% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -5198.133% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -889.613% |
| BeiGene, Ltd. | -881.7 Million USD | 66.536% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -1285.616% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 32.384% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -273.698% |
| Erasca, Inc. | -125.04 Million USD | -135.963% |
| bluebird bio, Inc. | -211.91 Million USD | -39.233% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -5800.473% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 275.999% |
| DBV Technologies S.A. | -72.72 Million USD | -305.705% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -5800.473% |
| Moderna, Inc. | -4.71 Billion USD | 93.741% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -634.749% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -5081.823% |
| Molecular Templates, Inc. | -8.12 Million USD | -3531.869% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -388.595% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -164.861% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -117.989% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -515.733% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -108.623% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -53.346% |
| MacroGenics, Inc. | -9.05 Million USD | -3157.375% |
| RenovoRx, Inc. | -10.23 Million USD | -2783.63% |
| Adicet Bio, Inc. | -142.65 Million USD | -106.825% |
| Prime Medicine, Inc. | -198.13 Million USD | -48.917% |
| Aditxt, Inc. | -32.38 Million USD | -811.196% |
| Adagene Inc. | -18.94 Million USD | -1457.306% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3935.342% |
| Quantum-Si incorporated | -95.96 Million USD | -207.475% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -147.883% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1923.993% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 322.968% |
| SciSparc Ltd. | -5.12 Million USD | -5660.504% |
| Vericel Corporation | -3.18 Million USD | -9172.564% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -245258.159% |
| Minerva Neurosciences, Inc. | -30 Million USD | -883.335% |
| Generation Bio Co. | -126.61 Million USD | -133.037% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -304.787% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -257.892% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -12.556% |
| Invivyd, Inc. | -198.64 Million USD | -48.534% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 13.72% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -3296.656% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1393.752% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -2888.181% |
| 2seventy bio, Inc. | -217.57 Million USD | -35.613% |
| ADMA Biologics, Inc. | -28.23 Million USD | -944.842% |
| Clene Inc. | -49.5 Million USD | -496.019% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -1223.847% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -496.862% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1036.272% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 10.063% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -806.658% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1398.649% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -198.662% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -294.699% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -83.485% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 52.029% |
| Evaxion Biotech A/S | -22.12 Million USD | -1233.573% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -265.454% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -47.476% |
| Trevena, Inc. | -40.28 Million USD | -632.341% |
| Surrozen, Inc. | -43.04 Million USD | -585.5% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -326.784% |
| Cingulate Inc. | -23.53 Million USD | -1153.68% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -4168.707% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -640.223% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -3726.553% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -227.073% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -381.436% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -395.862% |
| Clearmind Medicine Inc. | -11.95 Million USD | -2368.024% |
| Kronos Bio, Inc. | -112.67 Million USD | -161.867% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -326.396% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -11633426.928% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -243.504% |
| Statera Biopharma, Inc. | -174.4 Million USD | -69.174% |
| ImmunityBio, Inc. | -583.19 Million USD | 49.408% |
| Korro Bio, Inc. | -81.17 Million USD | -263.491% |
| Kineta, Inc. | -14.09 Million USD | -1992.723% |
| BioVie Inc. | -32.12 Million USD | -818.581% |
| Codexis, Inc. | -76.24 Million USD | -287.006% |
| Celularity Inc. | -196.29 Million USD | -50.311% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -37.535% |
| Celcuity Inc. | -63.77 Million USD | -362.617% |
| Virax Biolabs Group Limited | -6.73 Million USD | -4281.843% |
| Cibus, Inc. | -267.62 Million USD | -10.248% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -631.669% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -723.917% |
| IN8bio, Inc. | -30 Million USD | -883.281% |
| Kodiak Sciences Inc. | -260.49 Million USD | -13.268% |
| Annexon, Inc. | -134.23 Million USD | -119.8% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -151.827% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -381.892% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -835.37% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 19.447% |
| Eyenovia, Inc. | -27.26 Million USD | -982.323% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1466.556% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -55050.093% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -286.175% |
| Arcellx, Inc. | -70.69 Million USD | -317.39% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -611.983% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -120.492% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -882.298% |
| Moolec Science SA | -51.78 Million USD | -469.723% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -463.39% |
| Geron Corporation | -184.12 Million USD | -60.244% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -602.942% |
| Royalty Pharma plc | 1.13 Billion USD | 126.0% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -117.021% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -3218.258% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1288.927% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -71.872% |
| Humacyte, Inc. | -110.77 Million USD | -166.351% |
| Structure Therapeutics Inc. | -89.62 Million USD | -229.227% |
| 89bio, Inc. | -142.18 Million USD | -107.508% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -327.861% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -2743.336% |
| Genelux Corporation | -28.29 Million USD | -942.701% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -915.149% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -66.585% |
| Notable Labs, Ltd. | -11.26 Million USD | -2519.434% |
| Liquidia Corporation | -78.5 Million USD | -275.854% |
| Mustang Bio, Inc. | -51.6 Million USD | -471.786% |
| Immunovant, Inc. | -259.33 Million USD | -13.772% |
| Quantum-Si incorporated | -95.96 Million USD | -207.475% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -305.02% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1422.383% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -207.379% |
| Acasti Pharma Inc. | -12.85 Million USD | -2195.596% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -1213.807% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1748.511% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -61.768% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -6759.278% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -2266.103% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -900.485% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -656.779% |
| PepGen Inc. | -78.62 Million USD | -275.261% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -891.142% |
| United Therapeutics Corporation | 984.8 Million USD | 129.961% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -1225.485% |
| Solid Biosciences Inc. | -96.01 Million USD | -207.299% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -6057.886% |
| Immuneering Corporation | -53.47 Million USD | -451.794% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -5700.105% |
| Silo Pharma, Inc. | -3.7 Million USD | -7872.934% |
| Belite Bio, Inc | -31.63 Million USD | -832.767% |
| XOMA Corporation | -40.83 Million USD | -622.62% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -442.726% |
| Bionomics Limited | -15.49 Billion USD | 98.095% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -251.316% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -911.946% |
| uniQure N.V. | -308.47 Million USD | 4.352% |
| Cassava Sciences, Inc. | -97.21 Million USD | -203.499% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3935.342% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -139.045% |
| Forte Biosciences, Inc. | -31.47 Million USD | -837.39% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -3497.46% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -915.044% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -55050.093% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1024.783% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -1689.827% |
| Altimmune, Inc. | -88.44 Million USD | -233.593% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -94.647% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -911.946% |
| Compugen Ltd. | -18.75 Million USD | -1473.28% |
| Peak Bio, Inc. | -1259.26 USD | -23430565.629% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -540.737% |
| Benitec Biopharma Inc. | -21.75 Million USD | -1256.503% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 12.91% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -255.683% |
| Zura Bio Limited | -60.36 Million USD | -388.822% |
| PolyPid Ltd. | -23.86 Million USD | -1136.342% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -1775.496% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -255.683% |
| Instil Bio, Inc. | -156.08 Million USD | -89.031% |
| Immunome, Inc. | -106.8 Million USD | -176.251% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -594.34% |
| Verona Pharma plc | -54.36 Million USD | -442.686% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -195.298% |
| Shattuck Labs, Inc. | -87.29 Million USD | -237.984% |
| CervoMed Inc. | -2.17 Million USD | -13485.187% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -136.703% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -2115.778% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -577.426% |
| Moolec Science SA | -51.78 Million USD | -469.723% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -1706224.353% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -118.368% |
| AnaptysBio, Inc. | -163.61 Million USD | -80.329% |
| Design Therapeutics, Inc. | -66.86 Million USD | -341.287% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -262.411% |
| NeurAxis, Inc. | -14.62 Million USD | -1917.224% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -678.874% |
| Lumos Pharma, Inc. | -34.03 Million USD | -766.936% |
| Achilles Therapeutics plc | -69.66 Million USD | -323.531% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -195.298% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1380.067% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 9906.367% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -11633426.928% |
| Nutriband Inc. | -5.48 Million USD | -5278.963% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -193.011% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -507.018% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -282.733% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -768.569% |
| MoonLake Immunotherapeutics | -36 Million USD | -719.426% |
| Palisade Bio, Inc. | -12.3 Million USD | -2298.805% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -600.439% |
| Beam Therapeutics Inc. | -132.52 Million USD | -122.636% |
| Neurogene Inc. | -36.31 Million USD | -712.438% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -80.554% |
| AEON Biopharma, Inc. | -52.55 Million USD | -461.407% |
| Sesen Bio, Inc. | -19.88 Million USD | -1383.871% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -312.177% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -2257.803% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 33.552% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -164.465% |
| Athira Pharma, Inc. | -117.67 Million USD | -150.742% |
| Vaccinex, Inc. | -20.25 Million USD | -1356.98% |
| HCW Biologics Inc. | -24.99 Million USD | -1080.482% |
| XOMA Corporation | -40.83 Million USD | -622.62% |
| Nektar Therapeutics | -276.05 Million USD | -6.882% |
| Arvinas, Inc. | -367.3 Million USD | 19.67% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -438151.764% |
| Merus N.V. | -154.93 Million USD | -90.432% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -202.842% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -840.108% |
| Rezolute, Inc. | -68.45 Million USD | -330.992% |
| Clene Inc. | -49.5 Million USD | -496.019% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1813.013% |
| BeyondSpring Inc. | -21.02 Million USD | -1303.277% |
| Synlogic, Inc. | -57.28 Million USD | -415.089% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -2379.229% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -2625.411% |
| Peak Bio, Inc. | -1259.26 USD | -23430565.629% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -689.587% |
| Krystal Biotech, Inc. | 10.93 Million USD | 2798.985% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -106.188% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 9.244% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -6287.86% |
| MannKind Corporation | -11.93 Million USD | -2371.545% |
| Ikena Oncology, Inc. | -68.16 Million USD | -332.845% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1304.011% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -217.49% |
| Gossamer Bio, Inc. | -179.81 Million USD | -64.085% |
| CohBar, Inc. | -11.96 Million USD | -2366.561% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1044.148% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -878.617% |
| Legend Biotech Corporation | -518.25 Million USD | 43.068% |
| Mural Oncology plc | -207.44 Million USD | -42.231% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -137.725% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -1513.217% |
| Disc Medicine, Inc. | -76.42 Million USD | -286.048% |
| Champions Oncology, Inc. | -7.27 Million USD | -3955.154% |
| REGENXBIO Inc. | -263.49 Million USD | -11.977% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -2680.09% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -521.099% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -676.793% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -194.573% |
| Vaxart, Inc. | -82.46 Million USD | -257.792% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 88501.95% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -685.917% |
| Cellectis S.A. | -101.05 Million USD | -191.961% |
| Longeveron Inc. | -21.41 Million USD | -1277.915% |
| Repare Therapeutics Inc. | -93.79 Million USD | -214.569% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 44.95% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -314.581% |
| Revolution Medicines, Inc. | -436.36 Million USD | 32.384% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -4390.23% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -857.218% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -325.559% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -355.807% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -2907.369% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 108.152% |
| Denali Therapeutics Inc. | -145.22 Million USD | -103.171% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -245258.159% |
| Veru Inc. | -93.15 Million USD | -216.741% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -991.616% |
| Cingulate Inc. | -23.53 Million USD | -1153.68% |
| Passage Bio, Inc. | -102.06 Million USD | -189.092% |
| Context Therapeutics Inc. | -23.96 Million USD | -1131.224% |
| Exicure, Inc. | -16.91 Million USD | -1644.431% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -56.181% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -681.308% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -4434.168% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -59.766% |
| Nuvalent, Inc. | -126.21 Million USD | -133.763% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -2705.845% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -239.614% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -865.993% |
| OmniAb, Inc. | -50.61 Million USD | -482.89% |
| Anew Medical, Inc. | 1.34 Million USD | 22018.693% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -1738.909% |
| Lipocine Inc. | -16.35 Million USD | -1704.376% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -344.397% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -363.373% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -599.281% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -515.117% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1387.837% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 45.511% |
| Ocugen, Inc. | -63.07 Million USD | -367.759% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -208.207% |
| Q32 Bio Inc. | -112.96 Million USD | -161.199% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -1616.223% |
| Alumis Inc. Common Stock | -154.99 Million USD | -90.365% |
| Equillium, Inc. | -13.33 Million USD | -2112.621% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -388.773% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -3593.779% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -1465.166% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -399.396% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -157.627% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -1505.473% |
| Dominari Holdings Inc. | -22.88 Million USD | -1189.455% |
| Edesa Biotech, Inc. | -8.37 Million USD | -3423.267% |
| vTv Therapeutics Inc. | -20.25 Million USD | -1357.052% |
| Bio-Techne Corporation | 168.1 Million USD | 275.517% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 16.199% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 328.984% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -142.18% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -677.704% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -161.939% |
| Nkarta, Inc. | -117.5 Million USD | -151.107% |
| BioCardia, Inc. | -11.57 Million USD | -2449.935% |
| Iterum Therapeutics plc | -38.37 Million USD | -668.948% |